Greenville Health System Cancer Institute — Greenville, South Carolina

Greenville Health System Cancer Institute is a clinical research site located in Greenville, South Carolina, United States 29605-4255.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Greenville Health System Cancer Institute has participated in 13 clinical trials with 1 currently active.

Therapeutic areas: Colorectal Neoplasm, Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic.

Sponsors: Daiichi Sankyo Co., Ltd., Takeda, Prisma Health-Upstate.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Greenville Health System Cancer Institute?

Greenville Health System Cancer Institute has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Greenville Health System Cancer Institute conducted?

Greenville Health System Cancer Institute has 13 clinical trials on record, with 1 currently active. Their work covers Colorectal Neoplasm, Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic.

Is Greenville Health System Cancer Institute accredited by Crixeo Health?

Yes — Greenville Health System Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Greenville Health System Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.